Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) EPS (Weighted Average and Diluted) (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with $0.12 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 300.0% year-over-year to $0.12, compared with a TTM value of $0.41 through Sep 2025, down 29.31%, and an annual FY2024 reading of $0.48, up 14.29% over the prior year.
  • EPS (Weighted Average and Diluted) was $0.12 for Q3 2025 at SBC Medical Group Holdings, up from $0.02 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.21 in Q1 2025 and bottomed at -$0.02 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is $0.09, with a median of $0.06 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 900.0% in 2024, then tumbled 90.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.15 in 2023, then plummeted by 60.0% to $0.06 in 2024, then skyrocketed by 100.0% to $0.12 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SBC at $0.12 in Q3 2025, $0.02 in Q2 2025, and $0.21 in Q1 2025.